Gilead Sciences, Inc. (GILD)
144.74
-2.76
(-1.87%)
USD |
NASDAQ |
Oct 02, 16:00
144.92
+0.18
(+0.12%)
After-Hours: 20:00
Gilead Sciences Gross Profit Margin (Quarterly) : 79.81% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 79.81% |
| March 31, 2026 | 79.31% |
| December 31, 2025 | 79.65% |
| September 30, 2025 | 79.84% |
| June 30, 2025 | 78.75% |
| March 31, 2025 | 76.83% |
| December 31, 2024 | 79.09% |
| September 30, 2024 | 79.10% |
| June 30, 2024 | 77.78% |
| March 31, 2024 | 76.79% |
| December 31, 2023 | 78.05% |
| September 30, 2023 | 77.75% |
| June 30, 2023 | 78.12% |
| March 31, 2023 | 77.86% |
| December 31, 2022 | 86.75% |
| September 30, 2022 | 80.05% |
| June 30, 2022 | 76.80% |
| March 31, 2022 | 78.32% |
| December 31, 2021 | 70.85% |
| September 30, 2021 | 83.57% |
| June 30, 2021 | 77.72% |
| March 31, 2021 | 78.89% |
| December 31, 2020 | 82.03% |
| September 30, 2020 | 82.62% |
| June 30, 2020 | 79.24% |
| Date | Value |
|---|---|
| March 31, 2020 | 82.45% |
| December 31, 2019 | 71.22% |
| September 30, 2019 | 81.43% |
| June 30, 2019 | 82.30% |
| March 31, 2019 | 81.78% |
| December 31, 2018 | 72.84% |
| September 30, 2018 | 80.62% |
| June 30, 2018 | 78.99% |
| March 31, 2018 | 80.51% |
| December 31, 2017 | 78.40% |
| September 30, 2017 | 83.66% |
| June 30, 2017 | 83.73% |
| March 31, 2017 | 84.65% |
| December 31, 2016 | 84.84% |
| September 30, 2016 | 84.37% |
| June 30, 2016 | 88.50% |
| March 31, 2016 | 84.12% |
| December 31, 2015 | 87.01% |
| September 30, 2015 | 86.58% |
| June 30, 2015 | 87.27% |
| March 31, 2015 | 87.81% |
| December 31, 2014 | 85.01% |
| September 30, 2014 | 83.26% |
| June 30, 2014 | 85.30% |
| March 31, 2014 | 83.46% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 74.71% |
| Regeneron Pharmaceuticals, Inc. | 83.68% |
| Vertex Pharmaceuticals, Inc. | 85.37% |
| Amgen, Inc. | 72.08% |
| Biogen, Inc. | 61.37% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.39% |
| Return on Assets | -5.81% |
| Return on Invested Capital | -7.27% |
| Profit Margin (Quarterly) | -134.2% |
| Operating Margin (Quarterly) | 33.83% |
| Return on Net Operating Assets | -8.57% |